Montevideo, June 26, 2025 (GLOBE NEWSWIRE) -- Today, TIME has released its annual TIME100 Most Influential Companies list, which highlights companies making an extraordinary impact around the world. Not only is Mercado Libre the only Latin American company on the list, this year it’s recognized as the dominant retailer in the Titan category signaling the company’s global significance. Since its founding over 25 years ago, Mercado Libre has become a dominant force in the region. In recent years the company h ...

DENVER, June 26, 2025 (GLOBE NEWSWIRE) -- authID® [Nasdaq: AUID], a leading provider of biometric identity verification and authentication solutions, today reported that its Annual Meeting of Shareholders was duly held via webcast today, June 26, 2025 at 10:00 am Eastern Time. At the meeting, all the directors nominated were duly elected, and all resolutions proposed were duly adopted. About authID Inc. authID (Nasdaq: AUID) ensures enterprises “Know Who’s Behind the Device™” for every customer or employee ...

SINGAPORE, June 26, 2025 (GLOBE NEWSWIRE) -- Genius Group Limited (NYSE American: GNS) (“Genius Group” or the “Company”), a leading AI-powered, Bitcoin-first education group, today announced that its Board of Directors have approved a distribution plan from the proceeds of any and all future legal wins, with net proceeds divided equally for distribution to shareholders and purchase of Bitcoin for its Bitcoin Treasury. Genius Group’s CEO, Roger Hamilton said “The Company has two legal cases, one filed and on ...

PHOENIX, June 26, 2025 (GLOBE NEWSWIRE) -- WillScot Holdings Corporation (“WillScot” or the “Company”) (Nasdaq: WSC), North America’s leading provider of temporary space solutions, announced its support of the Borchetta Bourbon Music City Grand Prix as a presenting sponsor of the upcoming event, in partnership with Penske Entertainment Corp. Tim Boswell, President and Chief Operating Officer, commented, “As a leading provider of complete, turnkey space solutions for large-scale events, we are thrilled to be ...

Each year in North America about 500,000 crashes involve heavy-duty trucks.* To help avoid accidents, Volvo Trucks is leading the way to protect drivers and other road users. All-new Volvo VNL - Safety Exterior New collision avoidance technologies can detect vehicles, pedestrians, and cyclists around the truck, at certain distances, helping prevent crashes before they happen. By combining radar and cameras, these systems alert drivers to potential hazards ahead and on either side of the vehicle. All-ne ...

TORONTO, June 26, 2025 (GLOBE NEWSWIRE) -- Real Matters Inc. (“Real Matters”), a leading network management services provider for the mortgage lending and insurance industries, will announce its third quarter fiscal 2025 financial results via news release on Thursday, July 31, 2025, before market open. Conference Call and Webcast A conference call to review the results will take place at 10:00 a.m. (ET) on Thursday, July 31, 2025, hosted by Chief Executive Officer Brian Lang and Chief Financial Officer Rod ...

ANTIOCH, Tenn., June 26, 2025 (GLOBE NEWSWIRE) -- LKQ Corporation (Nasdaq: LKQ) will release its second quarter 2025 financial results on Thursday, July 24, 2025. Conference Call Details LKQ will host a conference call and webcast on July 24, 2025 at 8:00 a.m. Eastern Time (7:00 a.m. Central Time) with members of senior management to discuss the Company's results. To access the investor conference call, please dial (833) 470-1428. International access to the call may be obtained by dialing (404) 975-4839. T ...

NEW YORK, June 26, 2025 (GLOBE NEWSWIRE) -- Minerals Technologies Inc. (NYSE: MTX) (“MTI”) announced today that it will release results for its second quarter ended June 29, 2025, on Thursday, July 24, 2025, after the market close. MTI will host a conference call on Friday, July 25, 2025, at 11 a.m. Eastern Time (ET) to discuss these results. Investors and other interested parties can access the webcast and presentation materials on MTI’s Investor Relations page and pre-register for the webcast at any time ...

Shenzhen, China, June 26, 2025 (GLOBE NEWSWIRE) -- ugee, once heralded as the creative trailblazer in digital art, is now stepping into the audio world with the debut of FreSound Inspiration Open Earbuds. Staying true to its mission of escorting creative expression, ugee keeps close connections with artists to explore more possibilities. This move marks another new chapter for ugee, empowering creatives by merging inspiration with technology to deliver the exclusive experience tailored for creative communit ...

Core Insights - Everest Medicines is hosting a virtual event on June 30, 2025, to discuss the latest results from the Phase 1b/2a clinical trial of EVER001, a next-generation covalent reversible BTK inhibitor for treating Primary Membranous Nephropathy (pMN) [1][2] Group 1: Clinical Trial and Treatment Landscape - The event will provide an overview of pMN and the current treatment landscape in the U.S. and China, along with the latest data from the EVER001 trial as of March 21, 2025 [2] - Everest recently reported positive preliminary results from the EVER001 study at the European Renal Association, with patient follow-up data as of December 14, 2024 [3] - There are approximately 2 million patients with pMN in China and nearly 220,000 patients in the U.S., Europe, and Japan, with no approved drugs for this condition globally [3][6] Group 2: About EVER001 - EVER001, previously known as XNW1011, is a next-generation covalent reversible BTK inhibitor being developed for renal diseases [5] - BTK is crucial for B-cell receptor signaling pathways that regulate B lymphocyte functions, and targeting BTK has shown effectiveness in treating B-cell lymphomas and autoimmune diseases [5] Group 3: About Primary Membranous Nephropathy (pMN) - pMN is a common pathological type of nephrotic syndrome in adults, with its prevalence in China increasing, ranking second only to IgA nephropathy [6] - The current treatment goals for pMN include improving remission rates, reducing relapse rates, and minimizing chronic toxicity risks from existing treatments [6] Group 4: About Everest Medicines - Everest Medicines focuses on discovering, developing, manufacturing, and commercializing transformative pharmaceutical products and vaccines to address unmet medical needs [7][8] - The management team has extensive expertise from leading global and local pharmaceutical companies, with a portfolio of potentially first-in-class or best-in-class molecules in renal diseases, infectious diseases, and autoimmune disorders [8]